| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a9057130bebc2a1a84245318386110d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-813
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-14143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16722 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-869
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245 |
| filingDate |
1993-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a542e80460c9d732f9200d126b136f2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_393e7d7b7807cc4f5f7f68aa52e0ea39
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59e7d000dd142a81cc4b2a66fa733287
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a1402bb6977065f36c47172f008ee1d |
| publicationDate |
2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2116355-C |
| titleOfInvention |
Infectious bovine rhinotracheitis virus mutants and vaccines |
| abstract |
Mutants of the infectious bovine rhinotracheitis virus (bovine herpesvirus type 1 (BHV-1)), containing a deletion and/or insertion mutation in the gene coding for minor glycoprotein gI, whereby no expression of the glycoprotein by the virus occurs: inactivated, attenuated or subunit vaccines for infectious bovine rhinotracheitis (IBR) containing such strains: the use of said mutants as expression vectors; IBR vaccines and other bovine disease vaccines containing said mutants as expression vectors: methods for producing deleted viruses and expression vector viruses; and methods for using vaccines prepared from deleted mutants, or derivatives thereof, are disclosed. Animals vaccinated with said mutants or expression vectors derived therefrom do not develop antibodies to the viral glycoprotein having the deleted gene, and may be serologically distinguished from animals infected with diathetic BHV-1 strains. |
| priorityDate |
1992-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |